Skip to main content
. 2021 Jan 10;2021(1):CD013669. doi: 10.1002/14651858.CD013669.pub2

Comparison 1. Newer generation antidepressants (NGAs).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Repetition of SH by post‐intervention (NGA class) 2 129 Odds Ratio (M‐H, Random, 95% CI) 0.59 [0.29, 1.19]
1.1.1 Mianserin vs. Placebo 1 38 Odds Ratio (M‐H, Random, 95% CI) 0.67 [0.18, 2.41]
1.1.2 Paroxetine vs. Placebo 1 91 Odds Ratio (M‐H, Random, 95% CI) 0.55 [0.24, 1.29]
1.2 Repetition of SH at final follow‐up (by NGA class) 3 243 Odds Ratio (M‐H, Random, 95% CI) 0.75 [0.42, 1.35]
1.2.1 Mianserin vs. Placebo 2 95 Odds Ratio (M‐H, Random, 95% CI) 1.07 [0.39, 2.99]
1.2.2 Nomifensine vs. Placebo 1 57 Odds Ratio (M‐H, Random, 95% CI) 0.81 [0.17, 3.81]
1.2.3 Paroxetine vs. Placebo 1 91 Odds Ratio (M‐H, Random, 95% CI) 0.55 [0.24, 1.29]
1.3 Treatment acceptability 2 205 Odds Ratio (M‐H, Random, 95% CI) 0.70 [0.29, 1.71]